Skip to the page

Data / Form D filings / Precision Genetics, Inc.

Precision Genetics, Inc.: Form D filing

Precision Genetics, Inc., a pharmaceuticals company in Greenville, SC, filed a Form D with the SEC in 2025. The latest, on January 27, 2025, reports $1 million sold of a $1 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
430 ROPER MOUNTAIN ROAD, SUITE B, Greenville, SC, 29615
Phone
(864) 640-7992
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2051396

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 27, 2025New notice$1,000,000$1,000,0001May 30, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Nathan WilbourneExecutive Officer

Every Form D from the week of Jan 27, 2025 · All recent filings in South Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Precision Genetics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.